Acute ischemic stroke - from symptom recognition to thrombolysis

Acta Neurologica Scandinavica

Volumn 127, Issue S196, 2013, Pages 57-64

  Kurz, M W ^a   Kurz, K D ^a   Farbu, E ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Intravenous thrombolysis; Stroke; Transport times

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ARTICLE; AWARENESS; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EMERGENCY CARE; HELICOPTER; HOSPITAL CARE; HUMAN; MORBIDITY; MORTALITY; PATIENT TRANSPORT; THROMBECTOMY;

EID: 84870461306     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12051     Document Type: Article

References (51)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
2. O'Brien JT, Erkinjuntti T, Reisberg B et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-7.
4. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
5. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
6. Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82.
7. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54.
8. Saver JL. Time is brain-quantified. Stroke 2006;37:263-6.
9. Behrens S, Daffertshofer M, Interthal C, Ellinger K, van Ackern K, Hennerici M. Improvement in stroke quality management by an educational programme. Cerebrovasc Dis 2002;13:262-6.
10. Gil Nunez AC, Vivancos Mora J. Organization of medical care in acute stroke: importance of a good network. Cerebrovasc Dis 2004;17(Suppl 1):113-23.
11. Porteous GH, Corry MD, Smith WS. Emergency medical services dispatcher identification of stroke and transient ischemic attack. Prehosp Emerg Care 1999;3:211-6.
12. Evenson KR, Foraker RE, Morris DL, Rosamond WD. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke 2009;4:187-99.
13. Carroll C, Hobart J, Fox C, Teare L, Gibson J. Stroke in Devon: knowledge was good, but action was poor. J Neurol Neurosurg Psychiatry 2004;75:567-71.
14. Kozera G, Chwojnicki K, Gojska-Grymajlo A et al. Pre-hospital delays and intravenous thrombolysis in urban and rural areas. Acta Neurol Scand 2012;126:171-7.
15. Shah M, Makinde KA, Thomas P. Cognitive and behavioral aspects affecting early referral of acute stroke patients to hospital. J Stroke Cerebrovasc Dis 2007;16:71-6.
16. Lecouturier J, Murtagh MJ, Thomson RG et al. Response to symptoms of stroke in the UK: a systematic review. BMC Health Serv Res 2010;10:157.
17. Parahoo K, Thompson K, Cooper M, Stringer M, Ennis E, McCollam P. Stroke: awareness of the signs, symptoms and risk factors - a population-based survey. Cerebrovasc Dis 2003;16:134-40.
18. Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. BMJ 2002;325:17.
19. Salisbury HR, Banks BJ, Footitt DR, Winner SJ, Reynolds DJ. Delay in presentation of patients with acute stroke to hospital in Oxford. QJM 1998;91:635-40.
20. Moreira E, Correia M, Magalhaes R, Silva MC. Stroke awareness in urban and rural populations from Northern Portugal: knowledge and action are independent. Neuroepidemiology 2011;36:265-73.
21. Miley ML, Demaerschalk BM, Olmstead NL et al. The state of emergency stroke resources and care in rural Arizona: a platform for telemedicine. Telemed J E Health 2009;15:691-9.
22. Demaerschalk BM. Telestrokologists: treating stroke patients here, there, and everywhere with telemedicine. Semin Neurol 2010;30:477-91.
23. Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera and STRokE DOC Arizona telestroke trials. Telemed J E Health 2012;18:230-7.
24. Kohrmann M, Juttler E, Huttner HB, Nowe T, Schellinger PD. Acute stroke imaging for thrombolytic therapy-an update. Cerebrovasc Dis 2007;24:161-9.
25. Silliman SL, Quinn B, Huggett V, Merino JG. Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke 2003;34:729-33.
26. Walter S, Kostopoulos P, Haass A et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 2012;11:397-404.
27. Keskin O, Kalemoglu M, Ulusoy RE. A clinic investigation into prehospital and emergency department delays in acute stroke care. Med Princ Pract 2005;14:408-12.
28. Bouckaert M, Lemmens R, Thijs V. Reducing prehospital delay in acute stroke. Nature Rev Neurol 2009;5:477-83.
29. Lecouturier J, Rodgers H, Murtagh MJ, White M, Ford GA, Thomson RG. Systematic review of mass media interventions designed to improve public recognition of stroke symptoms, emergency response and early treatment. BMC Public Health 2010;10:784.
30. Evenson KR, Rosamond WD, Morris DL. Prehospital and in-hospital delays in acute stroke care. Neuroepidemiology 2001;20:65-76.
31. Mehdiratta M, Woolfenden AR, Chapman KM et al. Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can J Neurol Sci 2006;33:214-6.
32. Goldstein LB, Simel DL. Is this patient having a stroke? JAMA 2005;293:2391-402.
33. Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71-6.
34. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke. 1997;28:1530-40.
35. Lindsberg PJ, Happola O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006;67:334-6.
36. Douglas VC, Tong DC, Gillum LA et al. Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology 2005;64:422-7.
37. Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology 2003;61:792-6.
38. de Lucas EM, Sanchez E, Gutierrez A et al. CT protocol for acute stroke: tips and tricks for general radiologists. Radiographics 2008;28:1673-87.
39. Farbu E, Kurz KD, Kurz MW. Ischemic stroke-novel therapeutic strategies. Acta Neurol Scand Suppl 2011;000:28-37.
40. Allmendinger AM, Tang ER, Lui YW, Spektor V. Imaging of stroke: part 1, Perfusion CT-overview of imaging technique, interpretation pearls, and common pitfalls. Am J Roentgenol 2012;198:52-62.
41. Davis DP, Robertson T, Imbesi SG. Diffusion-weighted magnetic resonance imaging versus computed tomography in the diagnosis of acute ischemic stroke. J Emerg Med 2006;31:269-77.
42. Thomalla G, Cheng B, Ebinger M et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011;10:978-86.
43. Govan L, Weir CJ, Langhorne P, for the Stroke Unit Trialists C. Organized Inpatient (Stroke Unit) Care for Stroke. Stroke 2008;39:2402-3.
44. Epifanov Y, Dodel R, Haacke C et al. Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting. Health Policy 2007;81:339-49.
45. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019-26.
46. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New Engl J Med 2008;359:1317-29.
47. Wahlgren N, Ahmed N, Eriksson N et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008;39:3316-22.
48. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54.
49. Mazighi M, Meseguer E, Labreuche J, Amarenco P. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis. Stroke 2012;43:1302-8.
50. Georgiadis AL, Memon MZ, Shah QA et al. Comparison of partial (6 mg/kg) versus full-dose (9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis. J Neuroimaging 2011;21:113-20.
51. Khatri P, Hill MD, Palesch YY et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008;3:130-7.